Highlights from the 2025 Hospital Priorities Survey
Hospital executives report greater confidence in a positive budget outlook compared to previous surveys. Since the introduction of the medical insurance fund prepayment system in November 2024, 40% of surveyed hospitals claimed receipt of prepayments.
The push to use local medtech products has been a persistent trend, though interpretations of “local” vary — some hospitals consider factors beyond product manufacturing location.
Listing of National Reimbursement Drug List (NRDL)-negotiated drugs has been smoother, with approximately 50% of the public hospitals surveyed achieving automatic listing of NRDL-negotiated drugs. The prescription limit for NRDL drugs has also reduced meaningfully.
While offline channels remain the preferred method for clinician engagement with pharmas and medtechs, online platforms such as virtual conferences and company and third-party medical websites/apps are gaining traction.
Most of the public L3 hospitals surveyed plan to participate in or expand data transactions over the next one to three years — showing greater intent than public L2 and L1 and private hospitals.
To learn more about the priorities of hospitals in China for 2025, please be sure to download our analysis.
L.E.K. Consulting is a registered trademark of L.E.K. Consulting LLC. All other products and brands mentioned in this document are properties of their respective owners. © 2025 L.E.K. Consulting LLC
06202025090642